World's Best Scientists 2026 revealed!
VIEW LIST
Carlo Gambacorti-Passerini

Carlo Gambacorti-Passerini

University of Milano-Bicocca
Italy

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 87 13412 12620 513 492 531 41834

Carlo Gambacorti-Passerini publications per year

The chart shows the history of publications by Carlo Gambacorti-Passerini between 1985 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Carlo Gambacorti-Passerini published across 42 years, from 1985 to 2026, averaging 16.8 papers a year. Output peaked at 136 publications in 2023. 25 of the 707 publications appeared in the last two years.

No. of publications
25 50 75 100 125
Bar chart. Horizontal axis: year, 1985 to 2026. Vertical axis: number of publications, 0 to 136. Peak 136 publications in 2023. 1985: 1 publication 1986: 6 publications 1987: 2 publications 1988: 6 publications 1989: 4 publications 1990: 2 publications 1991: 2 publications 1992: 2 publications 1993: 7 publications 1994: 0 publications 1995: 3 publications 1996: 3 publications 1997: 3 publications 1998: 5 publications 1999: 4 publications 2000: 10 publications 2001: 4 publications 2002: 18 publications 2003: 9 publications 2004: 6 publications 2005: 10 publications 2006: 14 publications 2007: 14 publications 2008: 13 publications 2009: 9 publications 2010: 19 publications 2011: 26 publications 2012: 25 publications 2013: 31 publications 2014: 23 publications 2015: 30 publications 2016: 13 publications 2017: 32 publications 2018: 29 publications 2019: 35 publications 2020: 36 publications 2021: 19 publications 2022: 36 publications 2023: 136 publications 2024: 35 publications 2025: 24 publications 2026: 1 publication
1985 2026

707 publications in total across all disciplines

View publications per year as a table
Carlo Gambacorti-Passerini: publications per year, 1985 to 2026
Year Publications
1985 1
1986 6
1987 2
1988 6
1989 4
1990 2
1991 2
1992 2
1993 7
1994 0
1995 3
1996 3
1997 3
1998 5
1999 4
2000 10
2001 4
2002 18
2003 9
2004 6
2005 10
2006 14
2007 14
2008 13
2009 9
2010 19
2011 26
2012 25
2013 31
2014 23
2015 30
2016 13
2017 32
2018 29
2019 35
2020 36
2021 19
2022 36
2023 136
2024 35
2025 24
2026 1
Total 707
Download as CSV

Carlo Gambacorti-Passerini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carlo Gambacorti-Passerini sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 521–540 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 531 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610 531
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Carlo Gambacorti-Passerini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carlo Gambacorti-Passerini sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960 87
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Carlo Gambacorti-Passerini is affiliated with the University of Milano-Bicocca in Italy, focusing primarily on the field of medicine with a specialization in hematology.

The scientist's research contributions span several interconnected subfields, including hematology, genetics, public health, oncology, and molecular biology. This interdisciplinary approach is reflected in the topics they have extensively investigated:

  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Their recent publications include a range of studies published between 2020 and 2022, appearing in peer-reviewed journals with significant scientific reputations. Selected papers are as follows:

  • "Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study" (2020), The Lancet Haematology
  • "Integrative pathway enrichment analysis of multivariate omics data" (2020), Nature Communications
  • "Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis" (2020), Communications Biology
  • "Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial" (2022), Leukemia
  • "Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy" (2022), Blood

Frequent co-authors of this researcher, indicating active collaboration within the scientific community, include:

  • Rocco Piazza
  • Luca Mologni
  • Andrea Aroldi
  • Tim H. Brümmendorf
  • Pau Montesinos

The scientist has published regularly in specific venues, highlighting established channels for their research dissemination. The most common publication venues are:

  • Blood
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Nature Communications

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

    Hagop M Kantarjian;Charles Sawyers;Andreas Hochhaus;Francois Guilhot

  • Clinical and biological implications of driver mutations in myelodysplastic syndromes.

    Elli Papaemmanuil;Moritz Gerstung;Luca Malcovati;Sudhir Tauro

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

    Moshe Talpaz;Richard T. Silver;Brian J. Druker;John M. Goldman

  • Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

    E. Papaemmanuil;M. Cazzola;J. Boultwood;L. Malcovati

  • A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification.

    Philipp le Coutre;Elena Tassi;Marileila Varella-Garcia;Rossella Barni

  • Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

    Valentina Zuco;Rosanna Supino;Sabina C Righetti;Loredana Cleris

  • Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

    Jorge E. Cortes;Dong Wook Kim;Hagop M. Kantarjian;Tim H. Brümmendorf;Tim H. Brümmendorf

  • Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants

    Sara Redaelli;Rocco Piazza;Roberta Rostagno;Vera Magistroni

  • Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias

    Carlo B Gambacorti-Passerini;Rosalind H Gunby;Rocco Piazza;Annamaria Galietta

  • Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

    Jorge E. Cortes;Hagop M. Kantarjian;Tim H. Brümmendorf;Dong Wook Kim

  • Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

    Carlo Gambacorti-Passerini;Laura Antolini;Franois Xavier Mahon;Francois Guilhot

  • Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial

    Jorge E. Cortes;Dong Wook Kim;Javier Pinilla-Ibarz;Philipp D. le Coutre

  • In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

    Philipp le Coutre;Luca Mologni;Loredana Cleris;Edoardo Marchesi

  • Role of α1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL+ Leukemic Cells to the Abl Inhibitor STI571

    Carlo Gambacorti-Passerini;Rossella Barni;Philipp le Coutre;Massimo Zucchetti

  • Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

    Jorge E. Cortes;Carlo Gambacorti-Passerini;M. W. Deininger;Michael J. Mauro

Frequent Co-Authors

Jorge E. Cortes
Jorge E. Cortes Augusta University
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Tim H. Brümmendorf
Tim H. Brümmendorf RWTH Aachen University
Michael W. Deininger
Michael W. Deininger University of Utah
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Michele Baccarani
Michele Baccarani University of Bologna
Jane F. Apperley
Jane F. Apperley Imperial College London
Francois Guilhot
Francois Guilhot Grenoble Alpes University
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Leonardo Scapozza
Leonardo Scapozza University of Geneva

External Links

Wikipedia of Carlo Gambacorti-Passerini Personal website of Carlo Gambacorti-Passerini

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

In addition to traditional medical degrees, students are increasingly exploring alternative healthcare career pathways through flexible online programs. With the healthcare industry rapidly evolving, online degrees can open doors to a variety of high-demand fields without the need to attend campus full-time.

For those interested in pharmaceuticals, online pharmacy schools offer accredited programs leading to rewarding pharmacy careers. Similarly, managing medical data is a critical role, and many students pursue their education through online schools for health information management to work in record keeping, compliance, and data analysis.

The demand for skilled billing professionals is also on the rise. Affordably priced medical billing and coding online courses cost significantly less than traditional education, making this a popular choice for career changers and those seeking quick entry into the workforce.

Additionally, those looking to advance their nursing careers can find flexible options through the cheapest online fnp programs, positioning themselves for roles as family nurse practitioners (FNPs) in primary care settings.

Best Scientists Citing Carlo Gambacorti-Passerini

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 335

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 327

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 153

Andreas Hochhaus

Andreas Hochhaus

Friedrich Schiller University Jena

Publications: 150

Michael W. Deininger

Michael W. Deininger

University of Utah

Publications: 140

Brian J. Druker

Brian J. Druker

Oregon Health & Science University

Publications: 128

Timothy P. Hughes

Timothy P. Hughes

South Australian Health and Medical Research Institute

Publications: 114

Guillermo Garcia-Manero

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

Publications: 114

Michele Baccarani

Michele Baccarani

University of Bologna

Publications: 113

Giuseppe Saglio

Giuseppe Saglio

University of Turin

Publications: 111

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 107

Moshe Talpaz

Moshe Talpaz

University of Michigan–Ann Arbor

Publications: 96

Giovanni Martinelli

Giovanni Martinelli

University of Bologna

Publications: 90

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 81

Peter J. Campbell

Peter J. Campbell

Wellcome Sanger Institute

Publications: 80

Nicholas C.P. Cross

Nicholas C.P. Cross

University of Southampton

Publications: 75

Trending Scientists

Richard A. Soref

Richard A. Soref

University of Massachusetts Boston

Anand S. Murthy

Anand S. Murthy

Intel (United States)

Ih-Jen Su

Ih-Jen Su

National Health Research Institutes

Didier Robert

Didier Robert

University of Lorraine

Diane P. Hanger

Diane P. Hanger

King's College London

James P. Simmer

James P. Simmer

University of Michigan–Ann Arbor

Stuart A. Ralph

Stuart A. Ralph

University of Melbourne

Andreas Klügel

Andreas Klügel

University of Bremen

Shisan Bao

Shisan Bao

University of Sydney

Luca Mainetti

Luca Mainetti

University of Salento

Manzhou Zhu

Manzhou Zhu

Anhui University

Barbara Geddes

Barbara Geddes

University of California, Los Angeles

Graham Thornicroft

Graham Thornicroft

King's College London

Henrik Larsson

Henrik Larsson

Karolinska Institute

Martin W. Skov

Martin W. Skov

Bangor University

Pierre Ladevèze

Pierre Ladevèze

École Normale Supérieure Paris-Saclay

Related Medicine Rankings & Guides

September 2027 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

September 2027 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs
2027 Fastest Online MSN in Nursing Education Programs

2027 Fastest Online MSN in Nursing Education Programs
2027 Most Affordable Healthcare Administration Degrees Online

2027 Most Affordable Healthcare Administration Degrees Online
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
2027 Best Online Associate in Physical Therapy Assistant Programs

2027 Best Online Associate in Physical Therapy Assistant Programs
2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus
2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate

2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate
2027 Most Affordable Online AGNP Programs

2027 Most Affordable Online AGNP Programs
2027 Most Affordable Online Associate’s Degree in Radiology

2027 Most Affordable Online Associate’s Degree in Radiology
2027 Most Affordable LVN to RN Online Bridge Programs

2027 Most Affordable LVN to RN Online Bridge Programs
2027 Fastest Online Nutrition Degree Programs

2027 Fastest Online Nutrition Degree Programs
2027 Fastest Online MSN in Psychiatric Mental Health NP Programs

2027 Fastest Online MSN in Psychiatric Mental Health NP Programs
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs

September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
September 2027 Best Online Kinesiology Programs

September 2027 Best Online Kinesiology Programs
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs

Recently Published Articles

2027 How to Become a Dyslexia Specialist: Education, Salary, and Job Outlook

2027 How to Become a Dyslexia Specialist: Education, Salary, and Job Outlook
2027 Different Types of Social Work Degrees and Their Salaries

2027 Different Types of Social Work Degrees and Their Salaries
2027 What is Criminal Justice Administration? Salary & Career Paths

2027 What is Criminal Justice Administration? Salary & Career Paths
2027 Fastest Online Human Resource Management Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Human Resource Management Degree Programs You Can Finish in Under 2 Years
2027 Are Too Many Students Choosing Library Science? Oversaturation, Competition, and Hiring Reality

2027 Are Too Many Students Choosing Library Science? Oversaturation, Competition, and Hiring Reality
2027 Best Careers to Pursue with a Human Services Master’s Degree

2027 Best Careers to Pursue with a Human Services Master’s Degree
2027 Sports Management Degree Levels Explained: Bachelor's vs Master's vs Doctorate

2027 Sports Management Degree Levels Explained: Bachelor's vs Master's vs Doctorate
2027 BCBA vs School Psychologist: Career Comparison

2027 BCBA vs School Psychologist: Career Comparison
2027 How to Become a Kindergarten Teacher in Tennessee

2027 How to Become a Kindergarten Teacher in Tennessee
2027 Hardest and Easiest Courses in an Adult Gerontology Primary Care Nurse Practitioner Degree Program

2027 Hardest and Easiest Courses in an Adult Gerontology Primary Care Nurse Practitioner Degree Program
2027 Cheapest and Shortest Online Child Psychology Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Child Psychology Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 How to Become a Mental Health Counselor

2027 How to Become a Mental Health Counselor
2027 Occupational Therapy Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Occupational Therapy Degree Coursework Explained: What Classes Can You Expect to Take?
2027 Substance Abuse Counselor License: Requirements by State

2027 Substance Abuse Counselor License: Requirements by State
2027 Animation Degree Careers Ranked by Salary, Growth, and Work-Life Balance

2027 Animation Degree Careers Ranked by Salary, Growth, and Work-Life Balance
2027 Tennessee Nursing License Requirements

2027 Tennessee Nursing License Requirements
2027 Most Popular Concentrations in Management Information Systems Degrees

2027 Most Popular Concentrations in Management Information Systems Degrees
2027 Online Early Childhood Education Degree Programs Costs: Tuition & Fees

2027 Online Early Childhood Education Degree Programs Costs: Tuition & Fees
2027 Best Online Bachelor's Degrees in Physics

2027 Best Online Bachelor's Degrees in Physics
2027 Self-Paced Online Health Administration Degree Master's Programs

2027 Self-Paced Online Health Administration Degree Master's Programs
2027 Fastest Way To Become a Counselor in Hawaii

2027 Fastest Way To Become a Counselor in Hawaii